The Enterprise Value as of December 2025 (TTM) for Fennec Pharmaceuticals Inc. (FENC) is 192.39M

According to Fennec Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 192.39M. This represents a change of -3.68% compared to the average of 199.74M of the last 4 quarters.

Fennec Pharmaceuticals Inc. (FENC) Historical Enterprise Value (quarterly & annually)

How has FENC Enterprise Value performed in the past?

The mean historical Enterprise Value of Fennec Pharmaceuticals Inc. over the last ten years is 159.17M. The current 192.39M Enterprise Value has changed 11.99% with respect to the historical average. Over the past ten years (40 quarters), FENC's Enterprise Value was at its highest in in the December 2023 quarter at 318.75M. The Enterprise Value was at its lowest in in the June 2019 quarter at 59.39M.

Fennec Pharmaceuticals Inc. (FENC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fennec Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fennec Pharmaceuticals Inc. (FENC) Average Enterprise Value

How has FENC Enterprise Value performed in the past?

The current Enterprise Value of Fennec Pharmaceuticals Inc. (FENC) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Fennec Pharmaceuticals Inc. (FENC) Enterprise Value vs. Peers

How is FENC’s Enterprise Value compared to its peers?

Fennec Pharmaceuticals Inc.’s Enterprise Value is greater than Eupraxia Pharmaceuticals Inc. (188.01M), less than Aardvark Therapeutics, Inc. Common Stock (231.25M), greater than Cartesian Therapeutics, Inc. (48.64M), greater than Prelude Therapeutics Incorporated (53.80M), less than Caribou Biosciences, Inc. (194.64M), greater than Avalo Therapeutics, Inc. (175.77M), less than Enanta Pharmaceuticals, Inc. (469.35M), greater than Black Diamond Therapeutics, Inc. (139.57M), less than Nautilus Biotechnology, Inc. (264.58M), less than Orchestra BioMed Holdings, Inc. (247.47M),

Build a custom stock screener for Fennec Pharmaceuticals Inc. (FENC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fennec Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fennec Pharmaceuticals Inc. (FENC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fennec Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.